R&D Systems™ Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein

Catalog No.	Quantity
10108B7050	50 μg

Catalog No. 10108B7050 Supplier R&D Systems™ Supplier No. 10108B7050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 1-6 μg/mL.

Specifications

• Accession Number: XP_005548285
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in Citric Acid and NaCl with Trehalose.
• Gene ID (Entrez): 11148
• Molecular Weight (g/mol): M.W. (Observed): 92-109 kDa, reducing conditions; M.W. (theoretical): 64 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived cynomolgus monkey B7-H7/HHLA2 protein Cynomolgus Monkey B7-H7 (Ile21-Asn345) (N-terminus) Accession # XP_005548285 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <1.0 EU / 1 μg of the protein by the LAL method.
• Specific Reactivity: B7-H7/HHLA2
• Conjugate: Unconjugated
• Species: Cynomolgus Monkey
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 200 μg/mL aq. soln..
• Buffer: Lyophilized from a 0.2 μm filtered solution in Citric Acid and NaCl with Trehalose.
• Purity or Quality Grade: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Protein: B7-H7/HHLA2